TY - JOUR
KW - Buprenorphine/administration & dosage/therapeutic use
KW - Delayed-Action Preparations
KW - Health Services Accessibility
KW - Humans
KW - Injections
KW - Treatment Outcome
AU - E. Major
AU - C. W. Fusco
AU - Z. White
AU - C. G. Wilson
AU - E. B. Fagan
A1 - 
AD - Davidson Impact Fellow, Mountain Area Health Education Center, Asheville, North Carolina.; nurse practitioner, Mountain Area Health Education Center, Asheville, North Carolina.; program coordinator, office-based opioid treatment, Family Health Center, Mountain Area Health Education Center, Asheville, North Carolina.; associate director of pharmacotherapy, Mountain Area Health Education Center, Asheville, North Carolina; assistant professor of clinical education, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Courtenay.wilson@mahec.net.; family physician, Mountain Area Health Education Center, Asheville, North Carolina; chief education officer, UNC Health Sciences at MAHEC, Asheville, North Carolina; faculty, Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina; clinical consultant for the opioid crisis, Centers for Disease Control and Prevention Foundation, Atlanta, Georgia.
BT - North Carolina medical journal
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 3
CY - United States
DO - 10.18043/ncm.81.3.210
IS - 3
JF - North Carolina medical journal
LA - eng
M1 - Journal Article
PP - United States
PY - 2020
SN - 0029-2559; 0029-2559
SP - 210
EP - 211
EP - 
T1 - Long-acting, Injectable Buprenorphine: Great Promise, but Significant Barriers to Use
T2 - North Carolina medical journal
TI - Long-acting, Injectable Buprenorphine: Great Promise, but Significant Barriers to Use
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 32366637
U3 - 10.18043/ncm.81.3.210
VL - 81
VO - 0029-2559; 0029-2559
Y1 - 2020
Y2 - May-Jun
ER -